Volume 49, Issue 5 , Pages 409-411, July 2011
Lugol's iodine identifies synchronous invasive carcinoma—time for a clinical trial
Abstract
Lugol's iodine is currently under investigation as a technique to detect dysplasia, carcinoma in situ and invasive carcinoma at resection margins, plus further afield.
Lugol's iodine is inexpensive and easy to use. We present two cases where the technique revealed abnormal mucosa (one carcinoma, one squamous cell carcinoma in situ) at distant sites from the tumour being treated within oral cavity and oropharynx.
Keywords: Lugol's iodine, Squamous cell carcinoma, Head and neck cancer, Oral dysplasia
To access this article, please choose from the options below
PII: S0266-4356(10)00234-2
doi:10.1016/j.bjoms.2010.07.013
© 2010 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Volume 49, Issue 5 , Pages 409-411, July 2011
